Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
News

O.U. To Support Stem-cell Bill

The Orthodox Union is lending its support to a contentious House bill that would expand federal funding for embryonic stem-cell research.

The bill, the Stem Cell Research Enhancement Act of 2005, sponsored by Rep. Michael Castle, a Delaware Republican, and by Rep. Diana DeGette, a Colorado Democrat, seeks to extend federal funding to research on stem-cell lines derived from excess embryos created in fertility clinics. Currently federal law restricts funding for the research to several stem-cell lines derived before August 9, 2001.

The restrictions were enacted at the urging of Catholic and conservative Christian groups, which opposed the research because they believe embryos to be human beings. Proponents of the research — including most Jewish groups — believe that embryos outside the womb do not constitute human beings and that the benefits of such research outweigh the destruction of the cells.

In a letter to members of the House of Representatives, the union wrote, “By insisting that publicly funded stem-cell research be conducted on cells derived from embryos donated to IVF clinics in excess and were in excess of the clinical need of the individuals seeking IVF treatment, and by requiring prior consultation with and consent of the donors, the Stem Cell Research Enhancement Act serves to value and venerate the sanctity of life and our responsibilities to our fellow man and woman.”

The bill, which has 199 co-sponsors, is being opposed by some prominent conservatives and risks the veto of President Bush should it make it through both houses of Congress.

The director of the union’s Institute for Public Affairs, Nathan Diament, said the bill was “narrowly tailored” and had “broad bipartisan support.” He said the Orthodox Union wanted to show that “there are moral and religious arguments on both sides. There are scientific arguments on both sides.”

Also supporting the bill are Hadassah, the Christopher Reeve Paralysis Foundation, the American Diabetes Association and others.

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

Now more than ever, American Jews need independent news they can trust, with reporting driven by truth, not ideology. We serve you, not any ideological agenda.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and the protests on college campuses.

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

Make a gift of any size and become a Forward member today. You’ll support our mission to tell the American Jewish story fully and fairly. 

— Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version